Novel olanzapine analogues presenting a reduced H(1) receptor affinity and retained 5HT(2A)/D(2) binding affinity ratio

BACKGROUND: Olanzapine is an atypical antipsychotic drug with high clinical efficacy, but which can cause severe weight gain and metabolic disorders in treated patients. Blockade of the histamine 1 (H(1)) receptors is believed to play a crucial role in olanzapine induced weight gain, whereas the the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Somayeh, Bouillon, Marc E, Huang, Xu-Feng, Pyne, Stephen G, Fernandez-Enright, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485633/
https://www.ncbi.nlm.nih.gov/pubmed/22726212
http://dx.doi.org/10.1186/1471-2210-12-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485633/
https://www.ncbi.nlm.nih.gov/pubmed/22726212
http://dx.doi.org/10.1186/1471-2210-12-8

Ejemplares similares